<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6</volume><submitter>Benitez J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4> Thymic epithelial tumors (TETs) are rare malignancies of the anterior mediastinum with a high histopathological diversity from thymoma A to thymic carcinoma (TC). The biology of TETs is poorly understood and knowledge of the transcriptomic fingerprint of thymoma and TC is limited. Up to 30% of patients will develop associated autoimmune disorders, mainly myasthenia gravis (MG). We aimed to characterize main cancer activation pathways of TET subgroups. &lt;h4>Methods&lt;/h4> We selected a representative balanced set of thymoma and TCs to analyze 24 main cancer activation pathways using gene expression throughout Oncology biomarker panel (2,562 genes). Tumor representative paraffin-embedded blocks were macrodissected. Then, we merged data with The Cancer Genome Atlas (TCGA) dat</pubmed_abstract><journal>Mediastinum (Hong Kong, China)</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9792825</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>AB008. Activated pathways of Thymic Epithelial Tumors: a RYTHMIC study</pubmed_title><pmcid>PMC9792825</pmcid><pubmed_authors>Thomas de Montpreville V</pubmed_authors><pubmed_authors>Lacroix L</pubmed_authors><pubmed_authors>Scoazec J</pubmed_authors><pubmed_authors>Mercier O</pubmed_authors><pubmed_authors>Girard N</pubmed_authors><pubmed_authors>Saulnier P</pubmed_authors><pubmed_authors>Florez-Arango J</pubmed_authors><pubmed_authors>Lambotte O</pubmed_authors><pubmed_authors>Benitez J</pubmed_authors><pubmed_authors>Arana R</pubmed_authors><pubmed_authors>Molina T</pubmed_authors><pubmed_authors>Job B</pubmed_authors><pubmed_authors>Mussot S</pubmed_authors><pubmed_authors>Besse B</pubmed_authors><pubmed_authors>Fadel E</pubmed_authors></additional><is_claimable>false</is_claimable><name>AB008. Activated pathways of Thymic Epithelial Tumors: a RYTHMIC study</name><description>&lt;h4>Background&lt;/h4> Thymic epithelial tumors (TETs) are rare malignancies of the anterior mediastinum with a high histopathological diversity from thymoma A to thymic carcinoma (TC). The biology of TETs is poorly understood and knowledge of the transcriptomic fingerprint of thymoma and TC is limited. Up to 30% of patients will develop associated autoimmune disorders, mainly myasthenia gravis (MG). We aimed to characterize main cancer activation pathways of TET subgroups. &lt;h4>Methods&lt;/h4> We selected a representative balanced set of thymoma and TCs to analyze 24 main cancer activation pathways using gene expression throughout Oncology biomarker panel (2,562 genes). Tumor representative paraffin-embedded blocks were macrodissected. Then, we merged data with The Cancer Genome Atlas (TCGA) dat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-22T18:00:40.092Z</modification><creation>2025-04-06T02:20:11.905Z</creation></dates><accession>S-EPMC9792825</accession><cross_references/></HashMap>